[1]
|
刘明明, 李爱玲, 修瑞娟. 基质金属蛋白酶的研究进展[J]. 中国病理生理杂志, 2018, 34(10): 1914-1920.
|
[2]
|
Butler, G.S. and Overall, C.M. (2009) Updated Biological Roles for Matrix Metalloproteinases and New “Intracellular” Substrates Revealed by Degradomics. Biochemistry, 48, 10830-10845. https://doi.org/10.1021/bi901656f
|
[3]
|
Sbardella, D., Fasciglione, G.F., Gioia, M., et al. (2012) Human Matrix Metalloproteinases: An Ubiquitarian Class of Enzymes Involved in Several Pathological Processes. Molecular Aspects of Medicine, 33, 119-208.
https://doi.org/10.1016/j.mam.2011.10.015
|
[4]
|
Candelario-Ialil, E., Yang, Y. and Rosenberg, G.A. (2009) Diverse Roles of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Neuroinflammation and Cerebral Is-chemia. Neuroscience, 158, 983-994.
https://doi.org/10.1016/j.neuroscience.2008.06.025
|
[5]
|
Singh, D., Srivastava, S.K., Chaudhuri, T.K. and Upadh-yay, G. (2015) Multifaceted Role of Matrix Metalloproteinases (MMPs). Frontiers in Molecular Biosciences, 2, Article 19. https://doi.org/10.3389/fmolb.2015.00019
|
[6]
|
Nagase, H., Visse, R. and Murphy, G. (2006) Structure and Function of Matrix Metalloproteinases and TIMPs. Cardiovascular Research, 69, 562-573. https://doi.org/10.1016/j.cardiores.2005.12.002
|
[7]
|
张晓蕴, 李小刚. 基质金属蛋白酶-9与神经系统疾病[J]. 中国临床神经科学, 2008, 16(3): 312-317.
|
[8]
|
Galea, I. (2021) The Blood-Brain Barrier in Systemic Infection and In-flammation. Cellular & Molecular Immunology, 18, 2489-2501. https://doi.org/10.1038/s41423-021-00757-x
|
[9]
|
Constantinescu, C.S., Farooqi, N., O’Brien, K. and Gran, B. (2011) Experimental Autoimmune Encephalomyelitis (EAE) as a Model for Multiple Sclerosis (MS). British Journal of Pharmacology, 164, 1079-1106.
https://doi.org/10.1111/j.1476-5381.2011.01302.x
|
[10]
|
Dobson, R. and Giovannoni, G. (2019) Multiple Sclerosis: A Review. European Journal of Neurology, 26, 27-40.
https://doi.org/10.1111/ene.13819
|
[11]
|
Bennett, J., Basivireddy, J., Kollar, A., et al. (2010) Blood-Brain Barrier Disruption and Enhanced Vascular Permeability in the Multiple Sclerosis Model EAE. Journal of Neuroimmunology, 229, 180-191.
https://doi.org/10.1016/j.jneuroim.2010.08.011
|
[12]
|
耿会娟, 王雅杰, 伊正君, 等. MMP-9及其抑制剂TIMP-1与多发性硬化活动相关性研究[J]. 中华临床医师杂志(电子版), 2013, 7(11): 4816-4819.
|
[13]
|
Benesová, Y., Vasku, A., Novotná, H., et al. (2009) Matrix Metalloproteinase-9 and Matrix Metalloproteinase-2 as Biomarkers of Various Courses in Multiple Sclerosis. Multiple Sclerosis Journal, 15, 316-322.
https://doi.org/10.1177/1352458508099482
|
[14]
|
Kim, J.Y., Ko, A.R., Hyun, H.W. and Kang, T.C. (2015) ETB Receptor-Mediated MMP-9 Activation Induces Vasogenic Edema via ZO-1 Protein Degradation Following Status Epi-lepticus. Neuroscience, 304, 355-367.
https://doi.org/10.1016/j.neuroscience.2015.07.065
|
[15]
|
郭秀丽, 王传宝, 郭蕾. 实验性自身免疫性脑脊髓炎大鼠紧密连接蛋白表达的变化研究[J]. 中华神经医学杂志, 2018, 17(8): 772-777.
|
[16]
|
Thompson, K.K. and Tsirka, S.E. (2017) The Diverse Roles of Microglia in the Neurodegenerative Aspects of Central Nervous System (CNS) Auto-immunity. International Journal of Molecular Sciences, 18, Article 504.
https://doi.org/10.3390/ijms18030504
|
[17]
|
关鸿志, 王佳伟. 中国自身免疫性脑炎诊治专家共识[J]. 中华神经科杂志, 2017, 50(2): 91-98.
|
[18]
|
马建南, 蒋莉. 自身免疫性脑炎相关病因与致病机制[J]. 中华实用儿科临床杂志, 2019, 34(24): 1841-1845.
|
[19]
|
Ichiyama, T., Takahashi, Y., Matsushige, T., et al. (2009) Serum Matrix Metallopro-teinase-9 and Tissue Inhibitor of Metalloproteinase-1 Levels in Non-Herpetic Acute Limbic Encephalitis. Journal of Neurology, 256, 1846-1850.
https://doi.org/10.1007/s00415-009-5207-2
|
[20]
|
Matsuura, R., Hamano, S.I., Daida, A., et al. (2020) Serum Ma-trix Metallopeptidase-9 and Tissue Inhibitor of Metalloproteinase-1 Levels in Autoimmune Encephalitis. Brain and De-velopment, 42, 264-269.
https://doi.org/10.1016/j.braindev.2019.11.010
|
[21]
|
刘奔科. 儿童流行性乙型脑炎后继发自身免疫性脑炎的前瞻性研究[D]: [博士学位论文]. 重庆: 重庆医科大学, 2021.
|
[22]
|
Gelfand, J.M. (2018) Autoimmune Encephalitis af-ter Herpes Simplex Encephalitis: Insights into Pathogenesis. The Lancet Neurology, 17, 733-735. https://doi.org/10.1016/S1474-4422(18)30279-5
|
[23]
|
Danieli, D., Moraes, A.C.M., Alves, M.P., et al. (2017) An-ti-N-Methyl-D-Aspartate Receptor Encephalitis and Epstein-Barr Virus: Another Tale on Autoimmunity? European Journal of Neurology, 24, e46-e47.
https://doi.org/10.1111/ene.13332
|
[24]
|
Liu, B., Liu, J., Sun, H., et al. (2021) Autoimmune Encephalitis after Japa-nese Encephalitis in Children: A Prospective study. Journal of the Neurological Sciences, 424, Article ID: 117394. https://doi.org/10.1016/j.jns.2021.117394
|
[25]
|
周瑜, 曾艳平, 罗瑛, 等. MMP-9及MCP-1在单纯疱疹病毒性脑炎患者脑脊液中的表达及意义[J]. 临床急诊杂志, 2020, 21(3): 188-191.
|
[26]
|
Asgari, N., Berg, C.T., Mørch, M.T., Khorooshi, R. and Owens, T. (2015) Cerebrospinal Fluid Aquaporin-4-Immuno- globulin G Disrupts Blood Brain Barrier. Annals of Clinical and Translational Neurology, 2, 857-863.
https://doi.org/10.1002/acn3.221
|
[27]
|
Spencer, J.I., Bell, J.S. and Deluca G.C. (2018) Vascular Pathology in Mul-tiple Sclerosis: Reframing Pathogenesis around the Blood-Brain Barrier. Journal of Neurology, Neurosurgery & Psychi-atry, 89, 42-52.
https://doi.org/10.1136/jnnp-2017-316011
|
[28]
|
Hosokawa, T., Nakajima, H., Doi, Y., et al. (2011) Increased Se-rum Matrix Metalloproteinase-9 in Neuromyelitis Optica: Implication of Disruption of Blood-Brain Barrier. Journal of Neuroimmunology, 236, 81-86.
https://doi.org/10.1016/j.jneuroim.2011.04.009
|
[29]
|
Tasaki, A., Shimizu, F., Sano, Y., et al. (2014) Autocrine MMP-2/9 Secretion Increases the BBB Permeability in Neuromyelitis Optica. Journal of Neurology, Neurosurgery & Psychiatry, 85, 419-430.
https://doi.org/10.1136/jnnp-2013-305907
|
[30]
|
Uchida, T., Mori, M., Uzawa, A., et al. (2017) Increased Cerebro-spinal Fluid Metalloproteinase-2 and Interleukin-6 Are Associated with Albumin Quotient in Neuromyelitis Optica: Their Possible Role on Blood-Brain Barrier Disruption. Multiple Sclerosis Journal, 23, 1072-1084. https://doi.org/10.1177/1352458516672015
|